Swiss Homeopaths criticize swine flu vaccinations

by: continuum wellness - November 12th, 2009   Filed under: flu, healing philosophy, Health, health beliefs, Homeopathy, influenza vaccine, vaccination, vaccines, weekly reflection Add Comment

What do you think? Is there only one road to staying healthy in the winter time? And that consisting of flu vaccinations. We are taught for the most part in life to consider options, research for ourselves…learn to think. Why not when it comes to this issue? There are many powerful natural (vs. synthetic) substances which can enhance one’s immunity ranging from essential oils, to foods, to homeopathic remedies, herbs from the world’s rich storehouse of herbal legacies and probably even how one thinks! Why not health freedom? Why not apply these other areas of wisdom? Why not? I support the Swiss Homeopaths to have the freedom to speak their truth. Cheers.

Read the article below.

On National Vaccination Day and as Switzerland braces itself for a swine flu outbreak, the Swiss Association of Homeopathic Physicians has advised against the H1N1 jab.

In a statement of Friday, the homeopaths not only said the flu was by and large harmless but they also raised concerns over the two government-approved vaccines, Pandemrix and Focetria.

Above all the association criticized the use of so-called adjuvants, chemical compounds that increase the human body’s immune response, in the vaccines, saying they could lead to dramatic side-effects. The Swiss health authorities have however already said any side-effects, if any, are minor.

The Federal Health Office has recommended inoculating certain risk groups in a first wave – beginning in mid-November – including the chronically-ill, pregnant women and health staff, but stops short of mandatory jabs. After this, the wider public will be invited to be inoculated.

On Thursday health authorities warned the swine flu pandemic was expected to hit Switzerland with full force in the coming days, with confirmed cases of swine flu tripling last week to about 2,000.

In total tens of thousands of people with flu symptoms had consulted a doctor and were believed to have come down with a mild form of the illness. So far 38 people have been admitted to hospital, including six who are still in intensive care.

swissinfo.ch and agencies
a link to the news article –>here

Why the swine flu virus is not a major threat

by: continuum wellness - October 4th, 2009   Filed under: immune system, influenza vaccine, vaccination, vaccine damage, vaccine injury, vaccines 1 Comment

For the last 15 years, physician and epidemiologist Tom Jefferson, MD, has made it his mission to conduct extensive reviews of all studies of seasonal influenza vaccines. With colleagues at the Cochrane Collaboration, Dr. Jefferson has co-authored over 10 Cochrane reviews to answer a wide range of questions such as: do these vaccines reduce the chance of getting influenza or reduce the risk of complications, hospitalizations and deaths in elderly people, children, healthy adults and asthmatics? Based in Rome, Italy, Dr. Jefferson has published extensively and is, arguably, the world’s leading authority on the quality of the evidence supporting seasonal influenza vaccines. As we head into winter, the U.S. media is reporting a new, more ominous viral threat that may well become a pandemic. It is, of course, the swine flu, now known as the H1N1 virus or the 2009 H1N1 virus. Dr. Jefferson is interviewed by Maryann Napoli. click here for the rest of the story

Tags: , ,

Mercury, Autism and the Global Vaccine Agenda

by: continuum wellness - October 4th, 2009   Filed under: flu, influenza vaccine, vaccination, vaccine damage, vaccine injury, vaccines Add Comment

Worth watching!! For example, Denmark had mercury removed from vaccines and autism rates dropped by two-thirds. This site has excellent information to help you to understand the problem with mercury in vaccines. Note: mercury (thimerosol) is also included in flu vaccines.

Mercury, Autism and the Global Vaccine Agenda
a Video lecture by David Ayoub, MD

Thimerosol
Thimerosol and the Flu Vaccine

Tags: , ,

Research: Asoefetida is Anitviral Against Influenza

by: continuum wellness - September 28th, 2009   Filed under: herbal therapy, herbs, holistic, vaccination, vaccines Add Comment

Interesting article by the Washington Post link here.

You are not obligated to have a vaccine if you do not want to. There are other ways, other than vaccines, which actually build the immune system, which these vaccines do not do.

Recent research demonstrates the anitviral effect of the herb asoefetida against influenza. What is really interesting is that the interest is not in helping people only how to synthesize these natural agents into a drug. Why not promote health instead of poorly tested, hastily made vaccines?

Read more on Asafoetida.

Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
Lee CL, Chiang LC, Cheng LH, Liaw CC, Abd El-Razek MH, Chang FR, Wu YC.

Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan, Republic of China.

Two new sesquiterpene coumarins, designated 5′-acetoxy-8′-hydroxyumbelliprenin (1) and 10′R-acetoxy-11′-hydroxyumbelliprenin (2), and a new diterpene, 15-hydroxy-6-en-dehydroabietic acid (3), along with 27 known compounds, were isolated from a CHCl(3)-soluble extract of Ferula assa-foetida through bioassay-guided fractionation. The structures of the new metabolites 1-3 were identified by spectroscopic data interpretation and by the Mosher ester method. Compounds 4 and 6-13 showed greater potency against influenza A virus (H(1)N(1)) (IC(50) 0.26-0.86 microg/mL) than amantadine (IC(50) 0.92 microg/mL), and 11 exhibited the best potency (IC(50) 0.51, 2.6, and 3.4 microg/mL) of these compounds against the HepG2, Hep3B, and MCF-7 cancer cell lines, respectively.

Tags: ,

Children to be tested with Swine Flu vaccine

by: continuum wellness - August 20th, 2009   Filed under: drugs, flu, Pandora's box, vaccination, vaccines 1 Comment

The National Institute of Allergy and Infectious Diseases will soon schedule trials of Sanofi-Aventis’ vaccine in children aged 6 months to 17 years old. Vaccine and Treatment Evaluation units are used as the testing grounds. Several universities around the country conduct the tests. Supposedly this summer healthy adults were tested with no overarching problems presenting. The experiment was deemed successful enough that now children can be tested.
For more information, go here.

Tags: ,

Untested Swine Flu Vaccine, would you take the shot?

by: continuum wellness - July 27th, 2009   Filed under: flu, influenza vaccine, vaccination, vaccine damage, vaccine injury, vaccines 1 Comment

Interesting what is happening in the UK regarding the swine flu vaccine. Seems as if some want to force this vaccine on the public. And there is resistance. Who are the unfortunate ones who are “tested”? Consider that even with volunteers who decide to undergo testing, so much can still go wrong with these substances.
Apparently all pharmaceutical testing isn’t above board. What should one call it, if someone with access to humans, in such an intimate way as medical care desires to test a substance without a subjects knowledge? How ever you spin it, it is not for the greater good. In one recent case executives were indicted for unethical activity. Is it possible that other such cases could exist? At any rate, when it comes to immunity, the only real immunity is afforded by one having a healthy immune system.

Untested swine flu vaccine could put British public at risk, warn experts

EXPERTS have warned about the potential dangers of using untested vaccines as the British government prepares to fast-track inoculations against swine flu.
The European Medicines Agency, the EU’s top drug regulatory body, is accelerating the approval process for swine flu vaccine in order to have it ready before winter. (article here)

Tags: ,

Vaccine Aquisition Costs

by: continuum wellness - March 2nd, 2009   Filed under: children, vaccination, vaccines Add Comment

These prices reflect the current cost for a particular state as of February 2009. Thought some of you might like to know. Some doctors feel as the prices are high, here’s an article from the NY Times, here.

2009 List of Immunizing Agents and Average Wholesale Prices

Product Name, Company

 Brand/Product Name NDC Number Unit Dose AWP/
Dose*
Diphtheria Tetanus acellular Pertussis Vaccine (DTaP):
sanofi pasteur Tripedia 49281-0298-10 10 × 1 0.5 ml $26.37
sanofi pasteur Daptacel 49281-0286-10 10 × 1 0.5 ml $27.19
GlaxoSmithKline Infanrix 58160-0810-46 5 × 1 0.5 ml $23.02
GlaxoSmithKline Infanrix 58160-0810-11 10 × 1 0.5 ml $24.70
Tetanus Diphtheria acellular Pertussis Vaccine (TdaP):
sanofi pasteur Adacel 49281-0400-10 10 × 1 0.5 ml $44.46
sanofi pasteur Adacel 49281-0400-15 5 × 1 0.5 ml $44.46
GlaxoSmithKline Boostrix 58160-0842-11 10 × 1 0.5 ml $44.61
GlaxoSmithKline Boostrix 58160-0842-46 5 × 1 0.5 ml $44.61
Diphtheria Tetanus pediatric Vaccine (DT pediatric):
sanofi pasteur DT Pediatric 49281-0278-10 10 × 1 0.5 ml $34.57
Diphtheria Tetanus acellular Pertussis/Haemophilus Influenzae B (DTaP-HIB):
sanofi pasteur TriHIBit 49281-0597-05 5 × 1 0.5 ml $53.26
Tetanus Diphtheria adult Vaccine (Td adult):
sanofi pasteur Decavac 49281-0291-83 10 × 1 0.5 ml $23.09
sanofi pasteur Decavac 49281-0291-10 10 × 1 0.5 ml $23.09
Diphtheria, Tetanus, acellular Pertussis, Haemophilus Influenzae B, Polio (DTaP, HIB, IPV):
sanofi pasteur Pentacel 49281-0510-05 5 × 1 0.5 ml $86.74
Diphtheria, Tetanus, acellular Pertussis, Polio (DTap, IPV):
GlaxoSmithKline Kinrix 58160-0812-46 5 × 1 $57.00
GlaxoSmithKline Kinrix 58160-0812-11 10 × 1 $57.00
Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Polio (DTaP, Hep B, IPV):
GlaxoSmithKline Pediarix 58160-0811-11 10 × 1 0.5 ml $84.12
GlaxoSmithKline Pediarix 58160-0811-46 5 × 1 0.5 ml $84.12
Tetanus Toxoid:
sanofi pasteur Tetanus toxoid 49281-0820-10 10 × 1 0.5 ml $25.99
MassBiologics (Akorn, Inc) Tetanus toxoid
Haemophilus Influenzae Type B Vaccine (HIB):
sanofi pasteur ActHIB 49281-0545-05 5 × 1 10 mcg $27.25
Merck & Co. Pedvax HIB 00006-4897-00 10 × 1 7.5 mcg $27.32
Merck & Co. Recombivax HB Hepatitis B vaccine (Recombinant) Dialysis Formulation 4992-00-4992 each 1.0 ml $165.29
Injectable Polio Vaccine Inactivated (Salk Enhanced IPV):
sanofi pasteur IPOL 49281-0860-55 5.0 ml 0.5 ml $32.99
sanofi pasteur IPOL 49281-0860-10 5.0 ml 0.5 ml $28.53
Measles Mumps Rubella Vaccine (MMR):
Merck & Co. MMR II 00006-4681-00 10 × 0.5 0.5 ml $55.40
Measles Vaccine (Rubeola):
Merck & Co. Attenuvax 0006-4589-00 10 × 0.5 0.5 ml $20.48
Meningococcal Conjugate Vaccine (MCV4):
sanofi pasteur Menactra 49281-0589-05 5 × 1 0.5 ml $118.08
sanofi pasteur Menactra 49281-0589-15 5 × 1 0.5 ml $118.08
Meningococcal Polysaccharide Vaccine:
sanofi pasteur Menomune-A/C/Y/W-135 49281-0489-91 10 × 1 0.5 ml $118.08
sanofi pasteur Menomune-A/C/Y/W-135 49281-0489-01 each 0.05 mg $120.37
Mumps Vaccine:
Merck & Co. Mumpsvax 00006-4584-00 10 × 0.5 0.5 ml $26.54
Rubella Vaccine:
Merck & Co. Meruvax II 00006-4673-00 10 × 0.5 0.5 ml $22.83
Hepatitis A Vaccine (HEP-A):
Merck & Co. VAQTA syringe 00006-4096-31 1.0 ml 1.0 ml $77.89
Merck & Co. VAQTA syringe 00006-4096-06 6 × 1 1.0 ml $77.87
Merck & Co. VAQTA 00006-4841-00 1.0 ml 1.0 ml $76.21
Merck & Co. VAQTA 00006-4841-41 10 × 1 1.0 ml $71.99
Merck & Co. VAQTA Pediatric 00006-4831-41 10 × 0.5 0.5 ml $36.44
GlaxoSmithKline Havrix Pediatric 58160-0825-46 5 × 1 0.5 ml $34.34
GlaxoSmithKline Havrix Pediatric 58160-0825-11 10 × 1 0.5 ml $34.34
GlaxoSmithKline Havrix 58160-0826-46 5 × 1 1 ml $72.68
GlaxoSmithKline Havrix 58160-0826-11 10 × 1 1 ml $72.68
GlaxoSmithKline
Varicella Virus Vaccine:
Merck & Co. Varivax 00006-4826-00 each 1350 pfu $97.41
Merck & Co. Varivax 00006-4827-00 10 × 1 1350 pfu $92.86
Merck & Co. Zostavax 00006-4963-00 each 19400 pfu $193.80
Merck & Co. Zostavax 00006-4963-41 10 × 1 19400 pfu $184.72
Human Papilloma Virus Vaccine:
Merck & Co. Gardasil 00006-4045-00 each 0.5 ml $150.51
Merck & Co. Gardasil 00006-4045-41 10 × 1 0.5 ml $150.18
Merck & Co. Gardasil syringe 00006-4109-06 6 × 1 0.5 ml $152.54
Merck & Co Gardasil syringe w/o needle 00006-4109-09 6 × 1 0.5 ml $152.54
Rotavirus Vaccine:
Merck & Co. Rotateq 00006-4047-41 10 × 1 2 ml $83.35
GlaxoSmithKline Rotarix 58160-0805-11 10 × 1 1.0 ml $122.85
Influenza Virus Vaccine:
Novartis Fluvirin 66521-0109-01 10 × 1 0.5 ml $18.24
Novartis Fluvirin 66521-0109-10 10 × 1 0.5 ml $14.81
Sanofi pasteur Fluzone 49281-0008-10 10 × 1 0.5 ml $19.16
Sanofi pasteur Fluzone 49281-0008-50 10 × 1 0.5 ml $19.16
Sanofi pasteur Fluzone 49281-0382-15 10 × 1 0.5 ml $13.91
Sanofi pasteur Fluzone Pediatric 49281-0008-25 10 × 1 0.25 ml $17.77
GlaxoSmithKline Fluarix 58160-0873-46 5 × 1 0.5 ml $15.75
MedImmune Flumist 66019-0106-01 10 × 1 0.2 ml $24.44
CSL Biotherapies Afluria 33332-0108-10 Multidose 0.5 ml $13.20
CSL Biotherapies Afluria 33332-0008-01 10 × 1 0.5 ml $17.40
Hepatitis B Vaccine (HEP-B):
Merck & Co. Recombivax HB Pediatric 00006-4981-00 10 × 0.5 ml 0.5 ml $27.85
Merck & Co. Recombivax HB 00006-4995-00 1.0 ml 1.0 ml $71.64
Merck & Co. Recombivax HB 00006-4995-41 10 × 1.0 ml 1.0 ml $70.81
Merck & Co. Recombivax HB syringe 00006-4094-31 1.0 ml 1.0 ml $73.31
Merck & Co. Recombivax HB syringe 00006-4094-06 6 × 1.0 ml 1.0 ml $73.31
Merck & Co Recombivax HB syringe w/o needle 00006-4094-09 6 × 1.0 ml 1.0 ml $73.31
GlaxoSmithKline Engerix-B Pediatric 58160-0820-11 10 × 1 0.5 ml $25.49
GlaxoSmithKline Engerix-B Pediatric 58160-0820-46 5 × 1 0.5 ml $25.49
GlaxoSmithKline Engerix-B Pediatric 58160-0856-35 5 × 1 0.5 ml $25.49
GlaxoSmithKline Engerix-B 58160-0821-46 5 × 1 1.0 ml $62.85
GlaxoSmithKline Engerix-B syringe 58160-0821-11 10 × 1 1.0 ml $62.85
Hepatitis B / HIB:
Merck & Co. COMVAX 00006-4898-00 10 × 0.5 ml 0.5 ml $52.27
Hepatitis A & Hepatitis B Vaccine:
GlaxoSmithKline Twinrix 58160-0815-11 10 × 1.0 1.0 ml $103.43
GlaxoSmithKline Twinrix 58160-0815-46 5 × 1.0 1.0 ml $103.43
Pneumococcal Vaccine:
Wyeth Pharmaceuticals Prevnar 00005-1970-50 10 × 1 0.5 ml $100.51
Merck & Co. Pneumovax 23 00006-4739-00 2.5 ml 2.5 ml $197.93
Merck & Co. Pneumovax 23 00006-4943-00 10 × 1 0.5 ml $44.43
Measles, Mumps, Rubella and Varicella Vaccine
Merck & Co. ProQuad 00006-4999-00 10 × 0.5 0.5 ml $149.24
Tags: , ,

Vaccine Insanity: Caution for Pregnant Women

by: continuum wellness - September 4th, 2008   Filed under: Health, health beliefs, health care, infants, pregnancy, vaccination, vaccines, women, women's health Add Comment

This abstract suggests that pregnant women need to receive vaccinations during pregnancy. This is advice, really is reckless. Why not talk about reducing environmental hazards, and how to boost one’s natural immunity. We are really meant to interface with our environment without the need of vaccines. Illness and sickness do serve a purpose and as the body heals it becomes stronger and also the immune system is strengthened.

Vaccines for Pertussis and Influenza: Recommendations for Use in Pregnancy.

New Antibiotics and Vaccines in Obstetric Practice

Abstract:
The active immunization of pregnant women during pregnancy to protect them from disease and protect their neonate with passive antibodies is a biologic fact. Fortunately, many infectious diseases occur infrequently due to excellent pediatric vaccine programs. However, most adults and many physicians are unaware of the risks of not administering vaccines especially to pregnant women. Influenza vaccine (trivalent inactivated influenza vaccine) is recommended by (Advisory Committee on Immunization Practices (ACIP) for pregnant women in any trimester of pregnancy and Tetanus, reduced diphtheria, and pertussis (TdaP) vaccine is recommended by the ACIP to be given before pregnancy, during pregnancy, or in the immediate postpartum period. Only 2% of the adult US population is protected against pertussis and it is estimated that only 25% of pregnant women receive influenza vaccine during the influenza season. This chapter discusses trivalent inactivated influenza vaccine and TdaP use during pregnancy, the diseases they prevent, and the benefit to the neonate.

Tags:

1918 Flu Survivors, Still Immune After All These Years

by: continuum wellness - August 19th, 2008   Filed under: health beliefs, health care, healthy body, Homeopathy, vaccination, vaccines Add Comment

The body remembers. When our natural ability to fend off germs and viruses or other factors that may produce an illness is strengthened we become healthier, stronger, more adaptable. Vaccines do not strengthen the body in the same way is if one develops natural factors in an illness. That is one reason why they, meaning vaccines, have to be repeated. It is not “true” immunity. The influenza pandemic of 1918 was brutal. Some estimates say that up to 50 million people worldwide died as a result of the infection. Those who lived…by the way, there are many case records of those under homeopathic care surviving, still have immunity against those “superbugs”. (article here)

Tags: , ,

Gardasil Information

by: continuum wellness - July 24th, 2008   Filed under: adolescents, adverse events, HPV, medical news, Uncategorized, vaccination, vaccine damage, vaccine injury, vaccines, women's health Add Comment

Centers for Disease Control Gardasil reporting, here

A Homeopathic Perspective, here

Gardasil Human Papillomavirus (HPV) Vaccine

On June 8, 2006, the FDA licensed Gardasil®, the first vaccine developed to prevent cervical cancer caused by certain kinds of human papillomavirus (HPV). Since then, more than 12 million doses of Gardasil vaccine have been distributed. In 2006, a total of 2,151,000 doses were distributed and in 2007, another 11,317,902. At this time, the U.S. does not have a national registry for immunization and vaccination and therefore cannot report the total number of people who have received Gardasil.

The FDA has licensed the vaccine as safe and effective. This vaccine has been tested in thousands of females (9 to 26 years of age) around the world. These studies have shown no serious side effects. The most common side effect is brief soreness at the injection site. CDC, working with the FDA, will continue to monitor the safety of the vaccine after it is in general use.

CBS News story, here

Age for HPV vaccination.
Harper DM, Paavonen J.

Dartmouth College, Department of Women’s and Gender Studies, Obstetrics and Gynecology, Community and Family Medicine, Hanover, NH, USA. Diane.M.Harper@Dartmouth.edu

HPV vaccination of pre-pubescent girls will be effective for many girls. Vaccinating girls and women older than 12 years of age may accelerate the reduction in cervical cancer rates. Currently HPV vaccines are effective for at least 5 years in the prevention of HPV 16 and 18 associated precancerous lesions however the duration of vaccine protection is unknown. The need for booster shots must therefore be addressed with patients as unknown. Continued cervical cancer screening is necessary regardless of vaccination. Vaccination alone will not eliminate cervical cancer.

Vaccine. 2008 Mar 14;26 Suppl 1:A7-11

EMEA Statement On The Safety Of Gardasil, Europe

Article Date: 25 Jan 2008

The European Medicines Agency (EMEA) has received reports of deaths in women who had previously received Gardasil, including two reports concerning the sudden and unexpected deaths of two young women in the European Union (EU). Gardasil is a vaccine approved in the EU for the prevention of cervical cancer and other diseases caused by human papillomavirus (HPV) types 6, 11, 16 and 18. It is estimated that about 1.5 million patients have been vaccinated with this HPV vaccine in Europe.

The two European cases were reported as part of the continuous monitoring of the safety of medicines. One of the cases occurred in Austria and the other in Germany. In both cases, the cause of death could not be identified. No causal relationship has been established between the deaths of the young women and the administration of Gardasil.

On the basis of the currently available evidence, the EMEA’s Committee for Medicinal Products for Human Use (CHMP) is of the opinion that the benefits of Gardasil continue to outweigh its risks and that no changes to its product information are necessary.

The EMEA will continue to closely monitor the safety of Gardasil and take appropriate actions should new information emerge that has an impact on the benefit-risk profile of Gardasil.

Notes:

1. The approved indication in the EU for Gardasil is: “Gardasil is a vaccine for the prevention of high-grade cervical dysplasia (CIN 2/3), cervical carcinoma, high-grade vulvar dysplastic lesions (VIN 2/3), and external genital warts (condyloma acuminata) causally related to Human Papillomavirus (HPV) types 6, 11, 16 and 18. The indication is based on the demonstration of efficacy of Gardasil in adult females 16 to 26 years of age and on the demonstration of immunogenicity of Gardasil in 9- to 15-year old children and adolescents. Protective efficacy has not been evaluated in males. The use of Gardasil should be in accordance with official recommendations.” For more information on Gardasil, please see here.

2. HPV types 6, 11, 16 and 18 vaccine is also marketed in the EU as Silgard. For more information on Silgard, please see here.

Tags: ,
Content Protected Using Blog Protector Plugin By: Make Money.

Optimized by SEO Ultimate